Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Founded in 1997, Groupe Nature distributes organic health products, mainly food supplements and cosmetics, through organic specialty shops, pharmacies and online.

Also founded in 1997, Winco is a reference distributor in the French parapharmacy market.

Oaklins’ team in France advised Groupe Nature on the acquisition of Winco.

SERVICIO

M&A buy-side

PARTES

“We are very proud to integrate Winco into our group and we thank the Oaklins personal care and nutrition team for its commitment and expertise in achieving this transaction, which will allow us to extend our distribution channels to the health food industry and to develop Winco’s health product offering into the organic sector.”

Laurent Ducrocq

CEO, Groupe Nature

Contáctese con el equipo de la transacción

Ludovic Beaulieu

Asesor Senior

Paris, Francia
Oaklins France

Ver perfil Contáctenos

Transacciones relacionadas

MEDIK Hospital Design Group has been acquired by STERIS

Servicios de Construcción e Ingeniería | Salud

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Salud

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.

Banook, backed by Motion Equity, has acquired Fluidda

Salud | TMT

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.